Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Could US Drug Shortages Worsen After Aurobindo’s Eugia Plant Setbacks?

Company Targets EU Critical Medicines List

Feb 14 2024

• By Vibha Ravi

Shortage of medicines — Could US Drug Shortages Be Exacerbated?

Related Content

EU Publishes First Critical Medicines List In Drive To Tackle Shortages

Dec 12 2023

Aurobindo’s Pediatric AIDS Combo Generic Approved; Eugia Restructuring Back On Cards

Aug 17 2023

‘Is The Market Now Sustainable? The Answer Is Still Not’: AAM’s Haruvi On The Need To Fix The US Generics Industry

Feb 13 2024

Aurobindo Reverses Roles With Pfizer As It Drops Pin On Indonesia: What’s The Draw?

Sep 26 2023

Two Of Aurobindo’s Europe Biosimilar Filings Stuck, Licenses Ryzneuta From Yifan Pharma

Nov 23 2022

Aurobindo Expects To Be In Top Three For Immunology Biosimilar - Is It Xolair?

Jun 07 2022

US Drug Shortages Aid Aurobindo’s Q4 Growth, Decentralized Trials On For Xolair Biosimilar

Jun 01 2023

Merck, Serum Institute Face-off Looms With HPV Vaccination Support In India’s Interim Budget

Feb 02 2024

Related Companies

Intas Pharmaceuticals Ltd.

Aurobindo Pharma Limited

Additional Topics

India Asia Pacific United States Commercial Clinical Trials Business Strategies Biosimilars Sales & Earnings BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window